Bachem Adds 11 New Research Products to Online Catalogue
Bachem is continuously expanding and updating its extensive range of biologically active peptides, amino acid...
Bachem is continuously expanding and updating its extensive range of products for your research purposes. We are pleased to present our latest product additions, which include two N-terminal-derived peptides of Annexin A1, the somatostatin analog Vapreotide, the GP IIb/IIIa receptor antagonist Eptifibatide, Adrenomedullin 5, several building blocks and a range of new immunology products.
Our latest release of 18 new products includes:
Adrenomedullins
Adrenomedullin 5 (AM5) is a novel cardio- and vasoactive peptide with central and peripheral actions.
Annexin A1 Peptides
Annexin A1 (AnxA1) N-terminal-derived peptides which mimic the antiinflammatory effects of AnxA1. Ac2-26 represents the first endogenous ligand for FPRL2 (formyl peptide receptor-like 2) and exhibited cardioprotective effects in myocardial ischemia-reperfusion injury experiments.
Somatostatin and Analogs
Vapreotide is a potent octapeptide analog of somatostatin with selectivity for the somatostatin receptor subtypes SSTR-2 and SSTR-5.
Glycoprotein IIb/IIIa Receptor Antagonists
Building Blocks for Peptide Synthesis
Immunology Products
Visit our website to see the full list of new products.
Your opinion counts
We have created a survey to give you the opportunity to provide feedback on the quality of the last product additions. Visit our website to fill out the survey and you could win an original Swiss Army knife.
Bachem is continuously expanding and updating its extensive range of biologically active peptides, amino acid...
Bachem and Axon Neuroscience SE today announced that the two companies have entered into a...
Bachem is continuously expanding and updating its extensive range of biologically active peptides, amino acid...
Bachem is continuously expanding and updating its extensive range of products for your research purposes.We...